Celyad Oncology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 100,641 | 0.243% |
| Individual Insiders | 209,264 | 0.505% |
| Private Companies | 6,504,864 | 15.7% |
| General Public | 11,755,149 | 28.4% |
| VC/PE Firms | 22,858,654 | 55.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 83.4%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 22,858,654 | €7.8m | 187% | 1.29% | |||
| 6,504,864 | €2.2m | 0% | no data | |||
| 145,150 | €49.3k | -7.28% | no data | |||
| 72,641 | €24.7k | 0% | no data | |||
| 56,180 | €19.1k | 0% | no data | |||
| 28,000 | €9.5k | 0% | 0.37% | |||
| 7,300 | €2.5k | 0% | no data | |||
| 384 | €130.8 | 0% | no data | |||
| 250 | €84.4 | 0% | no data |